Life Sciences Research Partners VZW
Records under this name other than the patents Life Sciences Research Partners VZW holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Back to Life Sciences Research Partners VZW
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,662,232 | Immunogenic Peptides and Their Use in Immune Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 11,718,650 | Immunogenic Peptides and Their Use in Immune Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 9,248,171 | Immunogenic peptides and their use in transplantation Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,617,748 | Immunogenic control of tumours and tumour cells Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,044,507 | Elimination of immune responses to viral vectors Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,394,517 | CD4+ T-cells with cytolytic properties Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,999,346 | Immunogenic control of tumours and tumour cells Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,234,025 | Extracellular Allosteric Inhibitor Binding Domain from a Tyrosine Kinase Receptor Formerly held In force · High confidence | In force | High confidence | |
| US 9,249,202 | Immunogenic Peptides and Their Use in Immune Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 10,076,576 | Minimally toxic prodrugs Formerly held In force · USPTO record | In force | USPTO record |